Northern Trust’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,857
| Closed | -$13.4K | – | 4534 |
|
|
2023
Q2 | $13.4K | Hold |
1,857
| – | – | ﹤0.01% | 4457 |
|
|
2023
Q1 | $13.7K | Hold |
1,857
| – | – | ﹤0.01% | 4493 |
|
|
2022
Q4 | $12.4K | Hold |
1,857
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q3 | $19K | Hold |
1,857
| – | – | ﹤0.01% | 4558 |
|
|
2022
Q2 | $22K | Sell |
1,857
-6,394
| -77% | -$75.8K | ﹤0.01% | 4612 |
|
|
2022
Q1 | $175K | Sell |
8,251
-258
| -3% | -$5.47K | ﹤0.01% | 4175 |
|
|
2021
Q4 | $511K | Sell |
8,509
-199
| -2% | -$12K | ﹤0.01% | 3809 |
|
|
2021
Q3 | $817K | Sell |
8,708
-546
| -6% | -$51.2K | ﹤0.01% | 3613 |
|
|
2021
Q2 | $1.53M | Buy |
9,254
+22
| +0.2% | +$3.64K | ﹤0.01% | 3431 |
|
|
2021
Q1 | $1.78M | Buy |
+9,232
| New | +$1.78M | ﹤0.01% | 3304 |
|